Skip to main content
OpenTrials
Completed

NCT Number: NCT00665483

Design of Optimally-diagnostic Skin Test Solutions for Diagnosis of Sensitisation to a Pollen and Dust Mite Mixture.

Multicenter Skin Prick Test

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Type I Allergy

Age range

18 year–60 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Klinikum Darmstadt

Darmstadt, Hesse, 64297, Germany

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • anamnesis referring to suspicion of an IgE-mediated allergy
  • positive Skin Prick Test in the medical history to at least one of the investigational allergens with an existing anamnesis

Exclusion criteria

  • serious chronic diseases
  • Other perennial allergies

Treatment and study plan

Skin prick test

Other

Skin Prick Test

Primary outcomes

  1. Optimal trade-off between sensitivity and specificity

    Time frame: December 2007 - December 2008

Secondary outcomes

  1. Evaluation of the documentation of adverse events

    Time frame: January - December 2008

Sponsors and collaborators

Lead sponsor

Allergopharma GmbH & Co. KG

Industry

Registry information

Official study title

Design of Optimally-diagnostic Skin Test Solutions for Diagnosis of Sensitisation to a 6-grass Pollen Mixture, House Dust Mite (Dermatophagoides Pteronyssinus), Birch Pollen, and Mugwort Pollen

Important dates

Study start
2007
Primary completion
2007
Study completion
2010
First posted
Apr 24, 2008
Registry last updated
Nov 8, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.